Quantcast

Latest kidney cancer Stories

2010-11-19 06:55:00

NEW YORK, Nov. 19, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival (PFS) when compared to sorafenib, in the study population. Consistent with previous analyses, axitinib demonstrated a generally...

2010-10-27 20:31:28

Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants "” including those renowned for their apparent ability to prevent cancer "” may actually aggravate or even cause cancer in some individuals. Their recommendation follows a study in which two such antioxidants "” quercetin and ferulic acid "” appeared to aggravate kidney cancer in severely diabetic laboratory rats. The study appears in ACS' bi-weekly...

2010-10-11 12:14:00

SAN DIEGO, Oct. 11 /PRNewswire/ -- More than 120 cancer survivors and caregivers, cancer-treating physicians, and patient advocates gathered in San Diego to share their Proleukin® (aldesleukin for injection) treatment experiences. The theme of the meeting, Celebrating Our (Un)Common Journey Patient Summit, is believed to be the largest-ever gathering of metastatic renal cell carcinoma (kidney cancer) and metastatic melanoma (skin cancer) survivors. The Summit, which...

2010-10-04 09:00:00

LAS VEGAS, Oct. 4 /PRNewswire/ -- US Oncology, Inc., the nation's leading integrated cancer care company uniting the largest network of community-based oncologists to advance cancer care in America and improve the quality of life for cancer patients, announced today that Nicholas Vogelzang, M.D., oncologist and renowned investigator at Comprehensive Cancer Centers of Nevada (CCCN), an affiliate of the United Network of US Oncology, was presented with the prestigious Eugene P. Schonfeld...

2010-09-09 01:02:11

Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants "” including those renowned for their apparent ability to prevent cancer "” may actually aggravate or even cause cancer in some individuals. Their recommendation follows a study in which two such antioxidants "” quercetin and ferulic acid "” appeared to aggravate kidney cancer in severely diabetic laboratory rats. The study appears in ACS' bi-weekly...

2010-06-04 07:00:00

CHICAGO, June 4 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the first results from its collaboration with Pfizer Oncology to study early-stage renal cell carcinoma prognosis, which demonstrated a strong correlation between gene expression and recurrence risk in this patient population. The study, which will be presented in an oral presentation tomorrow (8 - 9:30 a.m. CT) at the ASCO annual meeting in Chicago, could lead to the development of a multi-gene...

2010-06-02 20:33:07

A minimally invasive technique used to destroy kidney tumors with an electrically controlled heating probe showed similar effectiveness as surgical removal of tumors in curbing cancer recurrence rates for up to five years after treatment. In an article available online in the journal Cancer, Dr. Jeffrey Cadeddu, professor of urology and radiology at UT Southwestern Medical Center, reported the outcomes of more than 200 patients who were treated with radiofrequency ablation (RFA). Once the...

2010-06-02 15:25:34

When kidney cancer spreads to other body parts, patients usually receive a poor prognosis. A new Mayo Clinic study examined the benefits of surgical treatment of kidney cancer, specifically renal cell carcinoma, and how patients saw improved prognosis of their cancer. These findings were presented today at the American Urological Association meeting in San Francisco. Each year in the United States, there are about 50,000 new cases of kidney cancer. In adults, the most common type of kidney...

2010-06-02 15:19:48

Kidney cancer is a radiographic diagnosis which means treatment decisions are often made based on the findings of a solid mass on CT or MRI. Unfortunately these tests cannot distinguish the different types of kidney cancers which have variable risks. As more Americans continue to be scanned as part of their evaluation for various ailments and symptoms, the number of kidney tumors found serendipitously has increased such that now up to 70 percent of kidney cancers are discovered incidentally....

2010-06-01 14:48:04

Fox Chase Cancer Center researchers will present three abstracts at the 2010 annual meeting of the American Urological Association (AUA) that demonstrate progress in the use of the R.E.N.A.L. Nephrometry Scoring to characterize renal mass anatomy and allow standardization of surgical decision-making and comparison of outcomes in patients with kidney cancers. Alexander Kutikov, M.D., working with Robert G. Uzzo, M.D., F.A.C.S., chairman of surgical oncology at Fox Chase Cancer Center, will...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related